Immunitas Therapeutics logo

Immunitas Therapeutics

Immuitas Therapeutics is a company using immunology for complex cancer treatment.

2

Funding Rounds

$97.0m

Money raised

Overview

Immuitas Therapeutics is a company using immunology for complex cancer treatment.

Funding series

Funding Series Analysis

The company Immunitas Therapeutics has raised a total of $58m in funding over 2 rounds.

Key Insights:

  • Immunitas Therapeutics Series B round, August 2021: $58m
  • Immunitas Therapeutics Series A round November 2019: $39m
Immunitas Therapeutics logo
Immunitas Therapeutics Series B round, August 2021 $58m
Immunitas Therapeutics logo
Immunitas Therapeutics Series A round November 2019 $39m

Industries

Immunitas Therapeutics is active in the following industries: